Stanley-Laman »

Catalyst Pharmaceutical Partners shares owned by Stanley-Laman

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Stanley-Laman from 13F filings

Historical chart of Stanley-Laman investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Stanley-Laman consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Stanley-Laman

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.8M 143k 19.70
2025-06-30 $3.1M 144k 21.70
2025-03-31 $3.5M 144k 24.25

More positions owned by Stanley-Laman

Microsoft Corporation (MSFT)
Alphabet Inc Class Class A Cap Stk Cl A (GOOGL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Asml Hldg N V F Sponsored Adr 1 Adr Reps 1 Ord N Y Registry Shs (ASML)
Cameco Corporation (CCJ)
Broadcom (AVGO)
Raytheon Technologies Corp (RTX)
Meta Platforms Inc Class A Cl A (META)
Apple (AAPL)
Arista Networks Com Shs (ANET)
Lam Resh Corp Com New (LRCX)
Linde
Taiwan Semiconductor M F Sponsored Adr 1 Adr Reps 5 Ord Sponsored Adr (TSM)
Monolithic Power Systems (MPWR)

View all positions for Stanley-Laman

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Renaissance Technologies
Fundsmith
Morgan Stanley
Geode Capital Management
American Century Companies
Dimensional Fund Advisors
Royce & Associates
Millennium Management
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
Robeco Investment Management

View all funds holding Catalyst Pharmaceutical Partners